Drug Trial Radar · NCT07478822
A Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in Multiple Treatments of Adult Upper Limb Spasticity
Last checked: Nov 19, 2026Latest source record: Apr 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
300
Planned (sponsor's estimate)
Start
Mar 27, 2026
Primary completion
Jun 1, 2027
Study completion Jun 1, 2027
Sponsor
- Lead sponsor
- Chongqing Claruvis Pharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Mar 18, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an open-label, multicenter, phase III clinical study to evaluate the long-term safety and efficacy of multiple treatments with recombinant botulinum toxin type A (YY001) for injection in adult upper limb spasticity
Conditions
- Upper Limb Spasticity
Interventions
Recombinant botulinum toxin type A for injection (YY001)Biological
Prepared by reconstitution of powder with 0.9% Sodium Chloride (NaCl), intramuscular injection, the total injection dose for single treatment is 200 to 400 U.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of Adverse Events and Serious Adverse EventsTime frame: Up to 48 weeks
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
Peking Union Medical College Hospital
Beijing, China · Recruiting
West China Hospital,Sichuan University
Chengdu, China · Recruiting
Guangdong Provincial People's Hospital
Guangdong, China · Recruiting
Sun Yat-sen Memorial Hospital
Guangzhou, China · Recruiting
The Second People's Hospital of Hefei
Hefei, China · Recruiting
Huai'an First Hospital Affiliated to Nanjing Medical University
Huai'an, China · Recruiting
The First Affiliated Hospital of Henan University
Kaifeng, China · Recruiting
The Second Affiliated Hospital of Kunming Medical University
Kunming, China · Recruiting
Shanghai Fudan University HuaShan Hospital
Shanghai, China · Recruiting
Yangzhi Affiliated Rehabilitation Hospital of Tongji University
Shanghai, China · Recruiting
Shenzhen Second People's Hospital
Shenzhen, China · Recruiting
The First Affiliated Hospital of Soochow University
Suzhou, China · Recruiting
Shanxi Bethune Hospital
Taiyuan, China · Recruiting
Tianjin Medical University General Hospital
Tianjin, China · Recruiting
Xuzhou Medical University Affiliated Hospital
Xuzhou, China · Recruiting
Zibo Municipal Hospital
Zibo, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.